JPWO2021059986A1 - - Google Patents

Info

Publication number
JPWO2021059986A1
JPWO2021059986A1 JP2021548779A JP2021548779A JPWO2021059986A1 JP WO2021059986 A1 JPWO2021059986 A1 JP WO2021059986A1 JP 2021548779 A JP2021548779 A JP 2021548779A JP 2021548779 A JP2021548779 A JP 2021548779A JP WO2021059986 A1 JPWO2021059986 A1 JP WO2021059986A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021548779A
Other versions
JPWO2021059986A5 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021059986A1 publication Critical patent/JPWO2021059986A1/ja
Publication of JPWO2021059986A5 publication Critical patent/JPWO2021059986A5/ja
Priority to JP2023198881A priority Critical patent/JP2024009228A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
JP2021548779A 2019-09-25 2020-09-09 Pending JPWO2021059986A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023198881A JP2024009228A (ja) 2019-09-25 2023-11-24 コラーゲン産生亢進剤、医薬品、化粧品、及びコラーゲン産生亢進剤の製造方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019174008 2019-09-25
PCT/JP2020/034171 WO2021059986A1 (ja) 2019-09-25 2020-09-09 コラーゲン産生亢進剤、医薬品、化粧品、及びコラーゲン産生亢進剤の製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023198881A Division JP2024009228A (ja) 2019-09-25 2023-11-24 コラーゲン産生亢進剤、医薬品、化粧品、及びコラーゲン産生亢進剤の製造方法

Publications (2)

Publication Number Publication Date
JPWO2021059986A1 true JPWO2021059986A1 (ja) 2021-04-01
JPWO2021059986A5 JPWO2021059986A5 (ja) 2022-04-20

Family

ID=75165703

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021548779A Pending JPWO2021059986A1 (ja) 2019-09-25 2020-09-09
JP2023198881A Pending JP2024009228A (ja) 2019-09-25 2023-11-24 コラーゲン産生亢進剤、医薬品、化粧品、及びコラーゲン産生亢進剤の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023198881A Pending JP2024009228A (ja) 2019-09-25 2023-11-24 コラーゲン産生亢進剤、医薬品、化粧品、及びコラーゲン産生亢進剤の製造方法

Country Status (5)

Country Link
US (1) US20220202696A1 (ja)
EP (1) EP4043023A4 (ja)
JP (2) JPWO2021059986A1 (ja)
CN (1) CN114450019A (ja)
WO (1) WO2021059986A1 (ja)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005029490A (ja) * 2003-07-10 2005-02-03 Sosin:Kk チロシナーゼ阻害剤、活性酸素抑制剤及び皮膚外用剤
JP2006061091A (ja) * 2004-08-27 2006-03-09 Toyo Shinyaku:Kk シソの葉から得られる発酵物
JP2009242263A (ja) * 2008-03-28 2009-10-22 Maruzen Pharmaceut Co Ltd 抗老化剤、並びに、皮膚外用剤及び飲食品
JP2013100236A (ja) * 2011-11-07 2013-05-23 Dhc Co Ｂｂｆ２ｈ７発現増加剤
JP2017001960A (ja) * 2015-06-04 2017-01-05 株式会社日健総本社 抗炎症剤、抗酸化剤及び抗菌剤
JP2017222743A (ja) * 2016-06-13 2017-12-21 株式会社村田製作所 電磁波吸収剤、日焼け止め剤、光学部品、メガネ、及び電磁波吸収剤の製造方法
WO2017217350A1 (ja) * 2016-06-13 2017-12-21 株式会社村田製作所 抗菌抗ウイルス薬、抗菌抗ウイルス部材、及び抗菌抗ウイルス薬の製造方法
KR101889647B1 (ko) * 2017-02-18 2018-08-20 박병희 신규한 락토바실러스 하비넨시스 및 이의 용도
KR20180095767A (ko) * 2017-02-18 2018-08-28 박병희 신규한 락토바실러스 부크네리 및 이의 용도
JP2019142817A (ja) * 2018-02-21 2019-08-29 国立大学法人岐阜大学 エゴマ発酵抽出物の新規用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4990297B2 (ja) 2007-02-01 2012-08-01 株式会社Ｔｋバイオ研究所 ブドウ果皮・種子乳酸菌発酵物及びそれを利用した医薬
JP2009249365A (ja) 2008-04-10 2009-10-29 Kose Corp 細胞賦活剤、及び老化防止用皮膚外用剤
JP2009249366A (ja) 2008-04-10 2009-10-29 Kose Corp コラーゲン産生促進剤、及び老化防止用皮膚外用剤
JP5467106B2 (ja) 2008-07-31 2014-04-09 コリアナ・コズメティック・カンパニー・リミテッド 緑豆発酵−酵素抽出液を含む皮膚老化防止用化粧料組成物
KR20110032715A (ko) * 2009-09-24 2011-03-30 두리화장품 주식회사 노화방지 화장료 조성물 및 그 제조방법
KR101176528B1 (ko) * 2009-12-31 2012-08-24 주식회사 코리아나화장품 배암차즈기 추출물을 유효성분으로 함유하는 화장료 조성물
JP2012144446A (ja) * 2011-01-07 2012-08-02 Shiseido Co Ltd 抗酸化剤およびコラーゲン産生促進剤
WO2013099883A1 (ja) 2011-12-28 2013-07-04 株式会社山田養蜂場本社 IgA産生促進作用を有する新規乳酸菌及びその用途
KR102111752B1 (ko) * 2013-11-15 2020-05-15 주식회사 엘지생활건강 콜라겐 합성 촉진용 조성물
JP6462987B2 (ja) 2014-02-24 2019-01-30 株式会社ナガセビューティケァ アブラナ科植物の乳酸菌発酵物、該発酵物を含有する食品、化粧品及び上皮バリア増強剤、並びに該発酵物の製造方法
EP3564382B1 (en) 2016-12-28 2022-06-29 Yamada Bee Company, Inc. Fermented product and production method therefor
EP3875099A4 (en) * 2018-10-30 2022-07-27 Murata Manufacturing Co., Ltd. HEAT SHOCK PROTEIN GENE EXPRESSION REGULATOR, MEDICINAL PRODUCT, COSMETIC AND METHOD OF MANUFACTURING HEAT SHOCK PROTEIN GENE EXPRESSION REGULATOR

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005029490A (ja) * 2003-07-10 2005-02-03 Sosin:Kk チロシナーゼ阻害剤、活性酸素抑制剤及び皮膚外用剤
JP2006061091A (ja) * 2004-08-27 2006-03-09 Toyo Shinyaku:Kk シソの葉から得られる発酵物
JP2009242263A (ja) * 2008-03-28 2009-10-22 Maruzen Pharmaceut Co Ltd 抗老化剤、並びに、皮膚外用剤及び飲食品
JP2013100236A (ja) * 2011-11-07 2013-05-23 Dhc Co Ｂｂｆ２ｈ７発現増加剤
JP2017001960A (ja) * 2015-06-04 2017-01-05 株式会社日健総本社 抗炎症剤、抗酸化剤及び抗菌剤
JP2017222743A (ja) * 2016-06-13 2017-12-21 株式会社村田製作所 電磁波吸収剤、日焼け止め剤、光学部品、メガネ、及び電磁波吸収剤の製造方法
WO2017217350A1 (ja) * 2016-06-13 2017-12-21 株式会社村田製作所 抗菌抗ウイルス薬、抗菌抗ウイルス部材、及び抗菌抗ウイルス薬の製造方法
KR101889647B1 (ko) * 2017-02-18 2018-08-20 박병희 신규한 락토바실러스 하비넨시스 및 이의 용도
KR20180095767A (ko) * 2017-02-18 2018-08-28 박병희 신규한 락토바실러스 부크네리 및 이의 용도
JP2019142817A (ja) * 2018-02-21 2019-08-29 国立大学法人岐阜大学 エゴマ発酵抽出物の新規用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
竹内萌恵他: "エゴマおよびエゴマ発酵産物中成分によるコラーゲン産生促進メカニズムの解析", 日本農芸化学会中部支部第１８３回例会講演要旨集, vol. 183, JPN6020045387, 2018, pages 09, ISSN: 0004986670 *

Also Published As

Publication number Publication date
CN114450019A (zh) 2022-05-06
EP4043023A4 (en) 2023-11-22
EP4043023A1 (en) 2022-08-17
WO2021059986A1 (ja) 2021-04-01
US20220202696A1 (en) 2022-06-30
JP2024009228A (ja) 2024-01-19

Similar Documents

Publication Publication Date Title
BR112019017762A2 (ja)
BR112021017339A2 (ja)
BR112021013854A2 (ja)
BR112021017939A2 (ja)
BR112021017892A2 (ja)
BR112019016141A2 (ja)
AU2020104490A4 (ja)
BR112021017738A2 (ja)
BR112021017782A2 (ja)
BR112019016138A2 (ja)
BR112019016142A2 (ja)
BR112021017234A2 (ja)
BR112021017173A2 (ja)
BR112021017728A2 (ja)
BR112021017083A2 (ja)
BR112021017637A2 (ja)
BR112021008711A2 (ja)
BR112021012348A2 (ja)
BR112021018093A2 (ja)
BR112021013944A2 (ja)
BR112021013128A2 (ja)
BR112021017732A2 (ja)
BR112021015080A2 (ja)
BR112021017703A2 (ja)
BR112021016996A2 (ja)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220203

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220203

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230210

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230410

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230531

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230824